← Back to headlines
Bernstein Upgrades Takeda Pharmaceutical to Outperform
Bernstein has upgraded Takeda Pharmaceutical (TAK) to an 'Outperform' rating, suggesting a positive forecast for the company's stock performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
